The mechanism by which imeglimin inhibits gluconeogenesis in rat liver cells

AIMS: To understand the mechanism by which imeglimin (a new oral hypoglycemic agent whose phase 3 development program in Japan has now been completed) decreases hepatic glucose production. MATERIALS AND METHODS: We compared the effect of imeglimin and metformin on glucose production, ATP/ADP ratio,...

Full description

Saved in:
Bibliographic Details
Published in:Endocrinol Diabetes Metab
Main Authors: Vial, Guillaume, Lamarche, Frédéric, Cottet‐Rousselle, Cécile, Hallakou‐Bozec, Sophie, Borel, Anne‐Laure, Fontaine, Eric
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2021
Subjects:
Original Research Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8029524/
https://ncbi.nlm.nih.gov/pubmed/33855213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.211
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items